| Primary |
| Anxiety |
26.8% |
| Depression |
22.0% |
| Drug Use For Unknown Indication |
9.8% |
| Product Used For Unknown Indication |
7.3% |
| Suicide Attempt |
7.3% |
| Autism |
4.9% |
| Hypercholesterolaemia |
4.9% |
| Nausea |
4.9% |
| Attention Deficit/hyperactivity Disorder |
2.4% |
| Chills |
2.4% |
| Insomnia |
2.4% |
| Nervous System Disorder |
2.4% |
| Staphylococcal Infection |
2.4% |
|
| Nausea |
12.0% |
| Product Substitution Issue |
12.0% |
| Coeliac Disease |
8.0% |
| Depressed Level Of Consciousness |
4.0% |
| Depression |
4.0% |
| Hyperhidrosis |
4.0% |
| Influenza |
4.0% |
| Intestinal Polyp |
4.0% |
| Nightmare |
4.0% |
| Pneumonia |
4.0% |
| Rash |
4.0% |
| Respiratory Arrest |
4.0% |
| Serotonin Syndrome |
4.0% |
| Somnambulism |
4.0% |
| Syncope |
4.0% |
| Tachycardia |
4.0% |
| Tonic Clonic Movements |
4.0% |
| Tremor |
4.0% |
| Unevaluable Event |
4.0% |
| Unresponsive To Stimuli |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
53.9% |
| Anxiety |
12.8% |
| Suicide Attempt |
10.2% |
| Depression |
5.6% |
| Hypertension |
3.0% |
| Schizophrenia |
1.9% |
| Hiv Infection |
1.5% |
| Pain |
1.5% |
| Bipolar Disorder |
1.3% |
| Completed Suicide |
1.3% |
| Depressed Mood |
0.9% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Asthma |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Major Depression |
0.7% |
| Psychotic Disorder |
0.7% |
| Smoking Cessation Therapy |
0.7% |
| Epilepsy |
0.6% |
| Insomnia |
0.6% |
| Post-traumatic Stress Disorder |
0.6% |
|
| Completed Suicide |
28.2% |
| Toxicity To Various Agents |
14.5% |
| Respiratory Arrest |
12.1% |
| Death |
6.5% |
| Poisoning |
5.6% |
| Cardio-respiratory Arrest |
4.0% |
| White Blood Cell Count Increased |
3.2% |
| Anxiety |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Electrocardiogram Qt Prolonged |
2.4% |
| Nausea |
2.4% |
| Suicide Attempt |
2.4% |
| Tremor |
2.4% |
| Bezoar |
1.6% |
| Cardiac Arrest |
1.6% |
| Depressed Level Of Consciousness |
1.6% |
| Depression |
1.6% |
| Headache |
1.6% |
| Hiccups |
1.6% |
| Unresponsive To Stimuli |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.7% |
| Anxiety |
13.1% |
| Depression |
10.6% |
| Pain |
4.7% |
| Bipolar Disorder |
4.0% |
| Hypertension |
3.6% |
| Drug Use For Unknown Indication |
3.5% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Smoking Cessation Therapy |
3.2% |
| Asthma |
2.5% |
| Blood Cholesterol Increased |
2.2% |
| Sleep Disorder |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Insomnia |
1.7% |
| Diabetes Mellitus |
1.7% |
| Crohn's Disease |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Migraine |
1.3% |
| Multiple Sclerosis |
1.3% |
| Fibromyalgia |
1.2% |
|
| Weight Decreased |
11.5% |
| Weight Increased |
8.2% |
| Drug Ineffective |
7.2% |
| Tremor |
7.2% |
| Pain |
6.3% |
| Pulmonary Embolism |
5.3% |
| Suicide Attempt |
5.3% |
| Suicidal Ideation |
4.8% |
| Vomiting |
4.8% |
| Nausea |
4.3% |
| Somnolence |
4.3% |
| Urinary Tract Infection |
4.3% |
| Anxiety |
3.4% |
| Depression |
3.4% |
| Headache |
3.4% |
| Nocturia |
3.4% |
| Pancreatitis |
3.4% |
| Paraesthesia |
3.4% |
| Product Quality Issue |
3.4% |
| Death |
2.9% |
|
| Interacting |
| Anxiety |
20.5% |
| Schizophrenia |
13.6% |
| Schizophrenia, Paranoid Type |
9.1% |
| Bipolar Disorder |
6.8% |
| Chills |
6.8% |
| Depression |
6.8% |
| Suicide Attempt |
6.8% |
| Bipolar I Disorder |
4.5% |
| Hypertension |
4.5% |
| Liver Disorder |
4.5% |
| Psoriatic Arthropathy |
4.5% |
| Smoking Cessation Therapy |
4.5% |
| Drug Therapy |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Staphylococcal Infection |
2.3% |
|
| Drug Interaction |
12.5% |
| Neuroleptic Malignant Syndrome |
12.5% |
| Rhabdomyolysis |
12.5% |
| Tachycardia |
12.5% |
| Tardive Dyskinesia |
12.5% |
| Tremor |
12.5% |
| Depression |
6.3% |
| Hypertension |
6.3% |
| Hypoxia |
6.3% |
| Insomnia |
6.3% |
|
